Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNAseq of tumor endothelial cells isolated from CT2A glioma under control or LGK974 treatment

ABSTRACT: RNAseq of tumor endothelial cells isolated from CT2A glioma under control or LGK974 treatment

PROVIDER: PRJNA839710 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19310291_1.fastq.gz	Fastqsanger.gz
	SRR19310291_2.fastq.gz	Fastqsanger.gz
	SRR19310292_1.fastq.gz	Fastqsanger.gz
	SRR19310292_2.fastq.gz	Fastqsanger.gz
	SRR19310293_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNAseq of tumor endothelial cells isolated from CT2A glioma under control or LGK974 treatment

Project description:The Wnt signaling pathway regulates blood-brain barrier (BBB) formation and function in both development and pathogenesis of diseases, and is essential for CNS angiogenesis and BBB formation in both embryonic and postnatal development. However, how Wnt signaling affects brain tumor endothelial cells is largely unknown. We isolated endothelial cells from tumors in control or LGK974 treated mice, and analyzed the role of Wnt signaling inhibition on tumor endothelial cells.

2023-03-31 | GSE203374 | GEO

Effect of inhibition of LDHA using FX11 on gene expression in CT2A glioma cells

Project description:To investigate the role of LDHA in regulating gene expression in glioma cells, we treated CT2A glioma cells with LDHA inhibitor FX11. We then performed gene expression profiling analysis using data obtained from RNA-seq of control and FX11-treated cells.

2023-11-09 | GSE216070 | GEO

Transcriptional analysis of ATRX deficiency in a CT2A glioma model

Project description:Transcriptional analysis of ATRX deficiency in a CT2A glioma model

| PRJNA949116 | ENA

Effects of the treatment with IFNβ and GM-CSF-secreting CT2A cells to wildtype CT2A tumor microenvironment post resection

Project description:To elucidate the underlying immune responses elicited by IFNβ and GM-CSF-secreting CT2A cells to brain tumor microenvironment post resection compared to placebo group and non-IFNβ and GM-CSF-secreting CT2A cell group

2022-11-09 | GSE217253 | GEO

Single-cell RNAseq analysis of wildtype and CaMKK2 KO immune infiltrate of CT2a preclinical murine glioma

Project description:Single-cell RNAseq analysis of wildtype and CaMKK2 KO immune infiltrate of CT2a preclinical murine glioma

| PRJNA812581 | ENA

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

Project description:A common cornerstone of preclinical cancer research is the use of syngeneic orthotopic murine tumors as immunocompetent models of human cancers. For glioblastoma research efforts, the GL261 and CT2A lines are frequently used. We systematically characterized these two lines to decipher the cell-intrinsic mechanisms that drive immuno-resistance in CT2A and to define the aspects of human cancer biology that the lines best model. We show that, despite sharing a few canonical genetic or histologic features of human glioblastoma, the transcriptional profiles of GL261 and CT2A tumours most closely resembled those of glioblastomas. CT2A additionally resembled other cancer types transcriptionally, including melanoma. CT2A displayed mesenchymal differentiation, upregulated angiogenesis, and multiple defects in antigen presentation machinery and interferon response pathways. Loss of MHC class I expression was restored in CT2A by interferon-γ treatment, explaining in part the modest efficacy of some immunotherapy combinations for CT2A. Our findings indicate that CT2A may serve as a robust preclinical solid tumor model of adaptive immune resistance.

2023-12-19 | PXD036720 | Pride

Effect of inhibition of LDHA using FX11 on gene expression in CT2A glioma cells

Project description:Effect of inhibition of LDHA using FX11 on gene expression in CT2A glioma cells

| PRJNA892026 | ENA

Transcriptional analysis of co-occuring ATRX deficiency and IDH1 mutation in a CT2A glioma model

Project description:Transcriptional analysis of co-occuring ATRX deficiency and IDH1 mutation in a CT2A glioma model

| PRJNA948443 | ENA

Single-cell RNAseq of control and COMT-KO glioma tumors in mice.

Project description:Next-generation sequencing (NGS)-derived transcriptomic profiling was carried out to compare the transcriptomic changes mediated by COMT knockout CT2A glioblastoma tumors using an orthotopic mouse model.

2023-10-12 | GSE238199 | GEO

The Wnt pathway inhibitor, LGK974 has suppressive effects for LPS-induced endotoxemia

Project description:We demonstrated that Wnt/β-catenin pathway was activated in in endotoxemic mice, and the modulation of this pathway by LGK974 had beneficial effects by suppressing the inflammation and lethality caused by endotoxemia.

2019-03-01 | GSE127459 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data